Arimidex in McCune Albright Syndrome

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00055302
First received: February 25, 2003
Last updated: August 31, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2015
  Primary Completion Date: February 2006 (Final data collection date for primary outcome measure)